Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

What new cannabis-based medications for PMR are being developed? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Polymyalgia rheumatica (PMR) remains a challenging condition to manage, with traditional therapies sometimes limited by side effects or reduced effectiveness. Recently, interest has grown in new cannabis-based medications for PMR that aim to provide safer and more targeted relief. These treatments are being designed to harness the therapeutic properties of cannabinoids while meeting pharmaceutical standards. 

The development of cannabis-based medications for PMR is closely tied to advances in research and regulation. Companies are working to transform raw cannabis extracts into approved medicines that offer consistent quality and predictable outcomes. This approach is intended to give patients confidence while expanding treatment choices. 

Can cannabis help my symptoms?

Areas of Research and Development 

Current efforts in the medical field highlight several directions where progress is being made. 

Pharmaceutical cannabis 

Researchers are refining pharmaceutical cannabis into precise formulations, ensuring consistent dosage and reducing variability seen in raw plant products. 

Clinical development 

Ongoing clinical development trials aim to confirm the safety and effectiveness of cannabis-derived therapies for PMR patients, focusing on reducing pain and inflammation. 

Innovative therapies and PMR 

Emerging innovative therapies and PMR research is exploring combinations of cannabinoids with other medicines, potentially creating new options for complex symptom management. 

As studies progress, the arrival of new cannabis-based medications for PMR may reshape treatment possibilities. By integrating pharmaceutical cannabis, focusing on robust clinical development, and exploring innovative therapies and PMR, patients could benefit from safer and more reliable solutions for managing their condition. 

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories